Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results

Demonstrates Potential for ET-02 to be Significantly More Effective Than Existing Treatments for Hair Loss WOBURN, Mass., Jan. 8, 2025 /PRNewswire/ — Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, announced…